Devices snaked into the brain artery of a patient experiencing a stroke should primarily be used within a clinical trial setting. Vascular neurologists at Mayo Clinic in Florida say the devices, known collectively as endovascular stroke therapy, should predominantly be limited to use within clinical trials.
A growing number of physicians who treat stroke are currently using these tools, so Kevin Barrett, M.D., co-medical director of Mayo Clinic’s Primary Stroke Center in Florida, acknowledges the recommendation to limit use will be controversial. The research is presented in Mayo Clinic Proceedings.
Read entire news release: Stroke Trials
Journalists: Sound bites with Dr. Barrett are available in the downloads